ORLANDO, Fla. — Older adults with diffuse large B-cell lymphoma (DLBCL) treated with the frontline chemotherapy regimen known as polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback